Mexico
· Delayed Price · Currency is MXN Moderna Statistics
Total Valuation
Moderna has a market cap or net worth of MXN 191.89 billion. The enterprise value is 43.02 billion.
| Market Cap | 191.89B |
| Enterprise Value | 43.02B |
Important Dates
The last earnings date was Thursday, May 1, 2025.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 386.74M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.05% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 360.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.96 |
| PB Ratio | 0.93 |
| P/TBV Ratio | 0.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.63 |
| EV / Sales | 0.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.52 |
Financial Position
The company has a current ratio of 4.22, with a Debt / Equity ratio of 0.07.
| Current Ratio | 4.22 |
| Quick Ratio | 3.92 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.19 |
| Interest Coverage | -196.26 |
Financial Efficiency
Return on equity (ROE) is -29.34% and return on invested capital (ROIC) is -18.75%.
| Return on Equity (ROE) | -29.34% |
| Return on Assets (ROA) | -15.84% |
| Return on Invested Capital (ROIC) | -18.75% |
| Return on Capital Employed (ROCE) | -33.59% |
| Revenue Per Employee | 11.20M |
| Profits Per Employee | -11.83M |
| Employee Count | 5,800 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 27.39 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.94% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -74.94% |
| 50-Day Moving Average | 585.37 |
| 200-Day Moving Average | 983.09 |
| Relative Strength Index (RSI) | 43.29 |
| Average Volume (20 Days) | 3,062 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.78 |
Income Statement
In the last 12 months, Moderna had revenue of MXN 64.93 billion and -68.61 billion in losses. Loss per share was -178.35.
| Revenue | 64.93B |
| Gross Profit | -53.49B |
| Operating Income | -76.22B |
| Pretax Income | -69.61B |
| Net Income | -68.61B |
| EBITDA | -72.29B |
| EBIT | -76.22B |
| Loss Per Share | -178.35 |
Balance Sheet
The company has 122.12 billion in cash and 15.23 billion in debt, giving a net cash position of 156.32 billion.
| Cash & Cash Equivalents | 122.12B |
| Total Debt | 15.23B |
| Net Cash | 156.32B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 205.74B |
| Book Value Per Share | 531.62 |
| Working Capital | 105.51B |
Cash Flow
In the last 12 months, operating cash flow was -62.38 billion and capital expenditures -19.87 billion, giving a free cash flow of -82.25 billion.
| Operating Cash Flow | -62.38B |
| Capital Expenditures | -19.87B |
| Free Cash Flow | -82.25B |
| FCF Per Share | n/a |
Margins
Gross margin is -82.37%, with operating and profit margins of -117.37% and -105.67%.
| Gross Margin | -82.37% |
| Operating Margin | -117.37% |
| Pretax Margin | -107.21% |
| Profit Margin | -105.67% |
| EBITDA Margin | -111.33% |
| EBIT Margin | -117.37% |
| FCF Margin | n/a |
Dividends & Yields
Moderna does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.05% |
| Shareholder Yield | -1.05% |
| Earnings Yield | -35.76% |
| FCF Yield | -42.86% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Moderna has an Altman Z-Score of 7.39.
| Altman Z-Score | 7.39 |
| Piotroski F-Score | n/a |